PT Medikaloka Hermina Tbk (IDX:HEAL)
820.00
-10.00 (-1.20%)
Jul 23, 2026, 3:49 PM WIB
PT Medikaloka Hermina Tbk Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, PT Medikaloka Hermina Tbk stock has a consensus rating of "Buy" and an average price target of Rp 1,504. The average 1-year stock price forecast is 83.44% higher than the current stock price, while the lowest is Rp 950.00 (+15.85%) and the highest is Rp 1,800 (+119.51%).
Price Target: Rp 1,504 (+83.44%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PT Medikaloka Hermina Tbk stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 5 | 6 | 7 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 1 | 1 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 11 | 12 | 13 |
Financial Forecast
Revenue This Year
7.79T
from 7.13T
Increased by 9.24%
Revenue Next Year
8.54T
from 7.79T
Increased by 9.55%
EPS This Year
33.07
from 28.40
Increased by 16.45%
EPS Next Year
40.39
from 33.07
Increased by 22.12%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is IDR.